Sign in
4

Changes in Ownership

Arcturus Therapeutics Holdings Inc. Filed Acc 0001209191-21-051182

Director sold 800,000 shares at an average $54.54 ($43,631,250)

From the SEC's structured data for this filing

Trades in this filing

Ultragenyx Pharmaceutical Inc. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-10 Sale : show line 1 in the form −725,000 $55.44 $40,194,000 1,475,000 D
2021-08-11 Sale : show line 2 in the form −75,000 $45.83 $3,437,250 1,400,000 D
Open-market sales · 800,000 sh · avg $54.54 · $43,631,250
Loading xslF345X03/doc4.xml…